首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Treatment of Brucella-susceptible mice with IL-12 increases primary and secondary immunity
Authors:Sathiyaseelan Janaki  Goenka Radhika  Parent Michelle  Benson Rita M  Murphy Erin A  Fernandes Dancella M  Foulkes Andrea S  Baldwin Cynthia L
Institution:Department of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA 01003, USA.
Abstract:Celiac disease is a gluten-induced T-cell mediated autoimmune process that results in the destruction of the intestinal mucosa and is associated with an expansion of CD8(+) CD103(+) TCRalphabeta intraepithelial lymphocytes (IELs) in the damaged epithelium. The role of this IEL population in the pathology is unknown. The aim of this work was to compare the cytokine profile and the cytotoxicity pattern from CD8(+) IEL clones isolated from celiac (CD) and non-celiac (NCD) biopsies. We report that the number of IL-10 producing CD clones was significantly lower (26%) than that obtained from the NCD sample (62%). Instead, IL-2 was produced by more CD (44%) than NCD clones (26%). Cytotoxicity patterns against intestinal epithelial cell lines suggest different functional subsets of CD8(+) IELs. CD clones capable of high cytotoxicity produced IL-2 whereas most cytotoxic NCD IELs produced IL-10. This clonal analysis indicates that an impaired immune regulation in celiac mucosa may be partially attributed to the low generation of regulatory CD8(+) IELs that produce IL-10.
Keywords:Brucellosis  Brucella  IL-12  IL-12Rβ2  Th1 immunity  Interferon-γ
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号